Recent Posts

Clinical trial harnesses power of natural killer cells to treat neuroblastoma

Now for the first time, scientists will combine NK cell therapy with an immunocytokine to target children with relapsed/refractory neuroblastoma including those with bulky tumors.

Read more: https://www.eurekalert.org/pub_releases/2018-11/skc-cth111418.php

Archive
Search By Tags